Schedule 13G ownership disclosure

ROIVANT SCIENCES LTD SHS

Common Shares, $0.0000000341740141 par value per share · CUSIP: G76279101

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • VIKING GLOBAL INVESTORS LP

    Shares: 23,594,831 · Class: 3.4%

  • VIKING GLOBAL PERFORMANCE LLC

    Shares: 12,504,401 · Class: 1.8%

  • Viking Global Equities II LP

    Shares: 250,088 · Class: 0.04%

  • Viking Global Equities Master Ltd.

    Shares: 12,254,313 · Class: 1.8%

  • Viking Long Fund GP LLC

    Shares: 4,851,726 · Class: 0.7%

  • Viking Long Fund Master Ltd.

    Shares: 4,851,726 · Class: 0.7%

  • Viking Global Opportunities Parent GP LLC

    Shares: 6,238,704 · Class: 0.9%

  • Viking Global Opportunities GP LLC

    Shares: 6,238,704 · Class: 0.9%

  • Viking Global Opportunities Portfolio GP LLC

    Shares: 6,238,704 · Class: 0.9%

  • Viking Global Opportunities Illiquid Investments Sub-Master LP

    Shares: 6,238,704 · Class: 0.9%

  • HALVORSEN OLE ANDREAS

    Shares: 23,594,831 · Class: 3.4%

  • Ott David C.

    Shares: 23,594,831 · Class: 3.4%

  • Shabet Rose Sharon

    Shares: 23,594,831 · Class: 3.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905148-25-004064
Form type
SCHEDULE 13G/A
Filer
Roivant Sciences Ltd.
CIK
CIK 1635088
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub